In experimental stroke models, we demonstrated that (1) plasma and brain LTB4 levels increased concomitantly post-stroke, (2) LTB4 loading increased infarct volume, and (3) attenuation of LTB4 production and BLTR antagonism decreased infarct volume. The gene discussed is LTB4R; the disease is Stroke.